ArticleJournal of the American Chemical Society2025

Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug.

Alexander I P Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.